Navigation Links
China Sky One Medical, Inc. to Acquire Peng Lai Jin Chuang Company
Date:6/12/2008

HARBIN, China, June 12 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (Amex: CSY) "China Sky One Medical," "CSY"), a manufacturer, marketer and distributor of pharmaceutical, medicinal and diagnostic kit products in China, today announced that it has signed an agreement to acquire Peng Lai Jin Chuang Company ("Jin Chuang"), a newly established pharmaceutical company that has obtained Good Manufacturing Practice Certification (GMP) approval issued by the country's State Food and Drug Administration (SFDA).

Under the terms of the agreement, China Sky One Medical's wholly-owned subsidiary, Harbin Tian Di Ren Medical Science and Technology Company, will acquire 100% of Jin Chuang's assets for a cash payment of RMB 17 million (US $2.5 million; 1 RMB = $0.14 US dollars) and RMB 32 million (US $4.6 million) of China Sky One Medical's common shares. In exchange, China Sky One Medical will obtain Jin Chuang's RMB 70 million (US $10.1 million) in assets, which includes franchise, production and operating rights for a portfolio of 20 approved drugs, including drugs for the treatment of colds, cardiovascular disease, and depression. The acquisition is expected to close on or before June 30, 2008.

"We expect the synergies that we will realize from this strategic acquisition to make a significant contribution to our profitability in the coming years," said Mr. Yan-qing Liu, Chairman, CEO and President of China Sky One Medical, Inc. "Specifically, Jin Chuang allows us to broaden our product lines and improve our manufacturing capabilities. We have been focused primarily on external use products; however following this acquisition a new pipeline of internal use drugs can enhance our product line. Since Jin Chuang is a newly established company and has not yet started production, we expect it will begin contributing to our profitability at the end of this year."

About Peng Lai Jin Chuang Company

Peng Lai Jin Chuang Company ("Jin Chuang"), Peng Lai Jin Chuang Group Corporation's wholly-owned subsidiary, has just been set up to develop, manufacture, and distribute pharmaceutical, medicinal and diagnogistic products in China. Jin Chuang's lead products include Chinese treatments for health improvement. Through its GMP-certified manufacturing facilities, Jin Chuang develops and manufactures drugs in various forms.

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company whose principal operations are through its subsidiaries, which are engaged in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic kit products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company (''TDR'') and Harbin First Bio- Engineering Company Limited ("First"), the Company manufactures and distributes over-the-counter pharmaceutical products as its primary revenue source. For more information, visit http://www.skyonemedical.com .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding our future plans, objectives or performance. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

For more information, please contact:

China Sky One Medical, Inc.

Mr. Xiaoqing Liao, CFO

Tel: +86-451-5399-4069

Email: cntiandiren@yahoo.com.cn

CCG Elite Investor Relations Inc.

Mr. Crocker Coulson, President

Tel: +1-646-213-1915 (New York)

Email: crocker.coulson@ccgir.com

Web: http://www.ccgelite.com


'/>"/>
SOURCE China Sky One Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. China Medical Technologies Reports Fourth Quarter and Full Year Financial Results
2. AmeriCares Establishes Field Hospital in China
3. China Sky One Medical, Inc. Announces Guidance for Second Quarter and Full Year 2008
4. AmeriCares Purchases BLU-MED Portable Hospital for China Earthquake Relief
5. Answers From Nature Introduces 100% Non-China Ingredients for Dietary Supplements
6. China Sky One Medical, Inc. Receives SFDA Approval for Five Patches
7. Meetings with Pre-Screened Verified China Suppliers Help 14 Top Buyers, Including Brookstone and Staples, Save Time and Cut Sourcing Costs
8. Free Wheelchair Mission to Distribute 4,400 Wheelchairs to China Earthquake Victims
9. China Nepstar Chain Drugstore Filed Its Annual Report on Form 20-F
10. China Sky One Medical, Inc. Donates RMB 1.1 Million in Medicine for Earthquake Disaster Relief Efforts
11. Mindray to Attend Morgan Stanley China Summit 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today ... efficacy of CM-AT in children aged 3-8 with Autism, is now enrolling at three ... enrolling children across the United States. , “There are currently no approved drugs ...
(Date:2/22/2017)... ... February 22, 2017 , ... When it came ... contact center in Georgia, PENETRON Specialty Products (PSP) provided the solution. January’s grand ... recently invested $51 million to purchase and renovate the 185,000 square-foot office complex, ...
(Date:2/22/2017)... ... 2017 , ... The Waismann Method® is providing a faster, safer, ... fallen victim to America’s opioid epidemic. Now, opiate dependent individuals can be treated in ... from the shame, stigma, and harmful labeling believed to prevent many of ...
(Date:2/22/2017)... N.J. (PRWEB) , ... February 22, 2017 , ... ... a one-size-fits-all approach, leads to fewer trips the emergency room, fewer hospital admissions, ... The American Journal of Managed Care® (AJMC®) finds. The study can be found ...
(Date:2/22/2017)... ... , ... Doctors on Liens is continuing its steady expansion of medical specialties ... at North Valley Eye Medical Group in Mission Hills . Eye injuries and ... injury cases. These injuries have a major impact on the quality of life ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 2017 Tillotts Pharma is strengthening ... Berlin office was opened in January 2017 ... portfolio includes Entocort ® for the treatment of ... ulcerative colitis, and VistaPrep ® for bowel preparation ... pharmaceutical company focused on the treatment of gastrointestinal (GI) ...
(Date:2/23/2017)... 23, 2017  Spheryx, Inc. will present ... at PittCon 2017 Conference and Exposition at ... world,s largest annual premier conference and exposition ... array of industry, academic and government communities ... food safety, environmental, bioterrorism and other emerging ...
(Date:2/23/2017)... 23, 2017 The U.S. cannabis market ... for recreational use in 2016. According to a new report ... worth an estimated $7.2 billion in 2016 and is projected ... While adult recreational sales are projected to jump from $2.6 ... 25% CAGR. The market may grow faster as the estimate ...
Breaking Medicine Technology: